Vistagen Therapeutics (VTGN) FCF Margin (QoQ) (2011 - 2026)
Vistagen Therapeutics (VTGN) FCF Margin (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Vistagen Therapeutics | 10.51 Mn | 10.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237,025.00 |
| Dec 31, 2025 | -52,544.00 |
| Sep 30, 2025 | 240,288.00 |
| Jun 30, 2025 | -7.41 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 147,047.00 |
| Sep 30, 2024 | 712,092.00 |
| Jun 30, 2024 | -947,730.00 |
| Mar 31, 2024 | -239,190.00 |
| Dec 31, 2023 | 90,397.00 |
| Sep 30, 2023 | 188,217.00 |
| Jun 30, 2023 | 60,086.00 |
| Mar 31, 2023 | 86,130.00 |
| Dec 31, 2022 | -357,506.00 |
| Sep 30, 2022 | 337,326.00 |
| Jun 30, 2022 | 3.43 Mn |
| Mar 31, 2022 | -3.61 Mn |
| Dec 31, 2021 | 161,383.00 |
| Sep 30, 2021 | -319,236.00 |
| Jun 30, 2021 | -58,533.00 |